Table S2 shows the calculated metabolic parameters. AUC glucose was significantly lower in the vildagliptin group from baseline to month 3, but returned to baseline values after 1 month from discontinuation. No differences were observed in insulin sensitivity, both at fasting (QUICKI) and in dynamic conditions (ISIcomp, OGIS). On the other hand beta cell function improved significantly after 3 months and remained slightly higher, though not significantly, at month 4.
Lifestyle modification All patients received instructions for lifestyle modification including structured advice for physical activity by a physician and dietary advice by a professional dietician (41). In the placebo group, however, no improvement of glycemicmetabolism orweight wasobserved aftermonths 3 or 4.
Table S2 shows the calculated metabolic parameters. AUC glucose was significantly lower in the vildagliptin group from baseline to month 3, but returned to baseline values after 1 month from discontinuation. No differences were observed in insulin sensitivity, both at fasting (QUICKI) and in dynamic conditions (ISIcomp, OGIS). On the other hand beta cell function improved significantly after 3 months and remained slightly higher, though not significantly, at month 4.Lifestyle modification All patients received instructions for lifestyle modification including structured advice for physical activity by a physician and dietary advice by a professional dietician (41). In the placebo group, however, no improvement of glycemicmetabolism orweight wasobserved aftermonths 3 or 4.
การแปล กรุณารอสักครู่..